March 17, 2020. A clinical trial of investigational vaccine for COVID-19 has begun. Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. Currently (March 17, 2020) no approved vaccines exist to prevent infection with SARS-CoV-2.
You may also like
Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
October 20, 2020
Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study
August 17, 2020
It is Time to Address Airborne Transmission of COVID-19
July 13, 2020